Nanoparticle-Doped Antibacterial and Antifungal Coatings
Polymers,
Journal Year:
2025,
Volume and Issue:
17(2), P. 247 - 247
Published: Jan. 20, 2025
Antimicrobial
polymeric
coatings
rely
not
only
on
their
surface
functionalities
but
also
nanoparticles
(NPs).
gain
properties
from
the
addition
of
NPs
into
a
matrix.
that
have
been
used
include
metal-based
NPs,
metal
oxide
carbon-based
nanomaterials,
and
organic
NPs.
Copper
silver
exhibit
antibacterial
antifungal
properties.
So,
when
present
in
coatings,
they
will
release
ions
with
combined
effect
having
bacteriostatic/bactericidal
properties,
preventing
growth
pathogens
surfaces
covered
by
these
nano-enhanced
films.
In
addition,
such
as
titanium
dioxide
(TiO2
NPs)
zinc
(ZnONPs)
are
antimicrobial
coatings.
Under
UV
irradiation,
show
photocatalytic
lead
to
production
reactive
oxygen
species
(ROS)
exposed
radiation.
After
various
forms
nano-carbon
materials
were
successfully
developed
over
past
decade,
derivatives
graphite/nanotubes,
composite
sheets
receiving
more
attention
because
share
an
extremely
large
area,
excellent
mechanical
strength,
etc.
These
ability
cause
oxidative
stress
chemicals
under
control,
resulting
long-lasting
action.
The
effectiveness
life
spans
antifouling
performance
variety
improved
adding
nano-sized
particles
those
Language: Английский
Chitosan and hyaluronic acid in breast cancer treatment: Anticancer efficacy and nanoparticle and hydrogel development
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
301, P. 140144 - 140144
Published: Jan. 21, 2025
Language: Английский
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases
Feng Gao,
No information about this author
Xuefei Feng,
No information about this author
Xinyu Li
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 24, 2025
The
liver
performs
crucial
roles
in
energy
metabolism,
detoxification,
and
immune
regulation.
Hepatic
diseases,
including
hepatitis,
fibrosis,
cancer,
have
posed
a
significant
threat
to
global
health,
emphasizing
the
critical
need
for
development
of
novel
effective
treatment
approaches.
Nanotechnology,
an
emerging
technology,
has
been
extensively
researched
medicine.
Among
many
types
nanomaterials,
polymeric
nanoparticles
(NPs)
are
widely
used
drug
delivery
systems.
Compared
traditional
therapies,
they
offer
advantages
disease
by
improving
outcomes
reducing
side
effects.
This
review
introduced
discussed
application
natural
polymers
synthetic
their
management.
Furthermore,
this
paper
reviewed
-mainly
chitosan
(CS),
hyaluronic
acid
(HA),
polyethylene
glycol
(PEG)
poly
(lactic-co-glycolic
acid)
(PLGA)-in
treatment,
focusing
on
use
various
systems
pure
bioactive
compounds
origin,
drugs,
nucleic
acids,
peptides,
others.
Finally,
challenges
future
perspectives
NPs
were
provide
guidance
further
research
directions,
with
aim
promoting
clinical
nanotherapeutics
treating
hepatic
diseases.
Language: Английский
Evaluation of Antimicrobial Properties and Antioxidant Activity of Rosmarinic Acid-Loaded Resomer RG 502 H-Based Nanoparticles Against Tert-Butyl Hydroperoxide-Induced Oxidative Stress: A detailed formulation, characterization and efficacy determination study
Büşra Solak,
No information about this author
Pervin Soyer,
No information about this author
Elif Kaya Tilki
No information about this author
et al.
Journal of Drug Delivery Science and Technology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106721 - 106721
Published: Feb. 1, 2025
Language: Английский
Arginine deiminase-polymeric hybrid nanoconjugates: A potential biodrug for targeted treatment of arginine auxotrophic cancers
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
311, P. 143679 - 143679
Published: May 1, 2025
Language: Английский
Re-purposing of Linagliptin for enhanced wound healing and skin rejuvenation via chitosan- modified PLGA Nanoplatforms
International Journal of Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
677, P. 125664 - 125664
Published: May 1, 2025
Language: Английский
Inducing disulfidptosis in tumors:potential pathways and significance
MedComm,
Journal Year:
2024,
Volume and Issue:
5(11)
Published: Oct. 15, 2024
Regulated
cell
death
(RCD)
is
crucial
for
the
elimination
of
abnormal
cells.
In
recent
years,
strategies
aimed
at
inducing
RCD,
particularly
apoptosis,
have
become
increasingly
important
in
cancer
therapy.
However,
ability
tumor
cells
to
evade
apoptosis
has
led
treatment
resistance
and
relapse,
prompting
extensive
research
into
alternative
processes
A
study
identified
a
novel
form
RCD
known
as
disulfidptosis,
which
linked
disulfide
stress.
Cancer
import
cystine
from
extracellular
environment
via
solute
carrier
family
7
member
11
(SLC7A11)
convert
it
cysteine
using
nicotinamide
adenine
dinucleotide
phosphate
(NADPH).
When
NADPH
deficient
or
its
utilization
impaired,
accumulates,
leading
formation
bonds
actin
cytoskeleton,
triggering
disulfidptosis.
Disulfidptosis
reveals
metabolic
vulnerability
tumors,
offering
new
insights
therapy
strategies.
This
review
provides
detailed
overview
mechanisms
underlying
current
progress,
limitations.
It
also
highlights
innovative
disulfidptosis
explores
potential
combining
these
approaches
with
traditional
therapies,
immunotherapy,
expedite
clinical
translation.
Language: Английский
Co-delivery of vinorelbine and rutin by lipid polymer nanoparticles for enhanced liver cancer chemotherapy
Journal of Drug Delivery Science and Technology,
Journal Year:
2024,
Volume and Issue:
unknown, P. 106490 - 106490
Published: Dec. 1, 2024
Language: Английский
Platelet Membrane-Coated HGF-PLGA Nanoparticles Promote Therapeutic Angiogenesis and Tissue Perfusion Recovery in Ischemic Hindlimbs
Peng Wang,
No information about this author
Xiao Di,
No information about this author
Fengshi Li
No information about this author
et al.
ACS Applied Bio Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 26, 2024
Therapeutic
angiogenesis
has
garnered
significant
attention
as
a
potential
treatment
strategy
for
lower
limb
ischemic
diseases.
Although
hepatocyte
growth
factor
(HGF)
been
identified
key
promoter
of
therapeutic
angiogenesis,
its
clinical
application
is
limited
due
to
short
half-life.
In
this
study,
we
successfully
developed
and
characterized
platelet
membrane-coated
HGF-poly(lactic-co-glycolic
acid)
(PLGA)
nanoparticles
(NPs).
These
demonstrated
enhanced
capabilities
promote
endothelial
cell
(EC)
proliferation,
migration,
tube
formation
in
vitro.
Additionally,
their
efficacy
improving
tissue
perfusion
promoting
was
confirmed
hindlimb
ischemia
rat
model.
Our
findings
suggest
that
HGF-PLGA-NPs
could
serve
promising
approach
enhancing
restoring
conditions.
Language: Английский